12 Feb 2025
// PRESS RELEASE
30 Jan 2025
// PRESS RELEASE
30 Oct 2024
// PRESS RELEASE
ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
About
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #9.1A94
28-30 October, 2025
Industry Trade Show
Exhibiting
25-27 November, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #9.1A94
28-30 October, 2025
Industry Trade Show
Exhibiting
25-27 November, 2025
https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination
https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-novo-s-parent-buys-catalent-for-us-16-5-bn-fujifilm-merck-kgaa-axplora-lonza-expand-capabilities
12 Feb 2025
// PRESS RELEASE
https://www.icepharma.com/news-articles/opening-of-a-new-warehouse-in-ice-japan-site/
30 Jan 2025
// PRESS RELEASE
https://www.icepharma.com/news-articles/ice-pharma-2023-2024-sustainability-report/
30 Oct 2024
// PRESS RELEASE
https://www.icepharma.com/news-articles/ice-pharma-joined-the-fifth-edition-of-fabbriche-aperte/
23 Sep 2024
// PRESS RELEASE
https://www.icepharma.com/news-articles/the-ambassador-of-italy-visits-ice-japan-plant/
05 Jan 2024
// PRESS RELEASE
https://www.icepharma.com/news-articles/the-potential-of-bile-acids-as-anti-covid-19-therapies/
04 Dec 2023
// PRESS RELAESE
https://www.icepharma.com/news-articles/ice-pharma-attended-cphi-india-2023/
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31188
Submission : 2016-11-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31049
Submission : 2016-09-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-25
Pay. Date : 2019-02-14
DMF Number : 16803
Submission : 2003-09-03
Status : Active
Type : II
Certificate Numbers : R1-CEP 2003-238 - Rev 01
Status : Valid
Issue Date : 2020-06-05
Type : TSE
Substance Number : 1189
Certificate Numbers : CEP 2000-334 - Rev 07
Status : Valid
Issue Date : 2024-04-03
Type : TSE
Substance Number :
Certificate Numbers : CEP 2000-202 - Rev 08
Status : Valid
Issue Date : 2024-04-03
Type : TSE
Substance Number :
Certificate Numbers : R1-CEP 2000-335 - Rev 03
Status : Valid
Issue Date : 2017-03-14
Type : TSE
Substance Number :
Certificate Numbers : R1-CEP 2001-331 - Rev 03
Status : Valid
Issue Date : 2020-06-05
Type : TSE
Substance Number :
Certificate Numbers : CEP 1999-047 - Rev 10
Status : Valid
Issue Date : 2024-10-28
Type : Chemical and TSE
Substance Number : 1275
Certificate Numbers : CEP 2005-198 - Rev 07
Status : Valid
Issue Date : 2024-07-24
Type : Chemical and TSE
Substance Number : 1275
Certificate Numbers : R1-CEP 2014-231 - Rev 00
Status : Valid
Issue Date : 2020-04-21
Type : Chemical
Substance Number : 1275
Certificate Numbers : R1-CEP 2010-376 - Rev 02
Status : Valid
Issue Date : 2022-04-26
Type : Chemical and TSE
Substance Number : 1275
Certificate Numbers : CEP 2024-006 - Rev 00
Status : Valid
Issue Date : 2024-08-21
Type : Chemical
Substance Number : 1275
ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
Registration Number : 304MF10051
Registrant's Address : Via Sicilia, 8/10 42122 Reggio Emilia, ITALY
Initial Date of Registration : 2022-03-10
Latest Date of Registration : 2023-02-02
ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
Registration Number : 218MF10319
Registrant's Address : Via Sicilia, 8/10 42122 Reggio Emilia, ITALY
Initial Date of Registration : 2006-03-09
Latest Date of Registration : 2024-04-03
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones....
Services
API Manufacturing
Pharma Service : API Manufacturing
Category : GMP Manufacturing
Sub Category : Overview
Pharma Service : API Manufacturing
Drug Product Manufacturing
API & Drug Product Development
Excipients
Excipients by Ingredients
Excipients By applications
Inspections and registrations
ABOUT THIS PAGE
ICE Pharma is a supplier offers 12 products (APIs, Excipients or Intermediates).
Find a price of Ursodeoxycholic Acid bulk with DMF, CEP, JDMF offered by ICE Pharma
Find a price of Chenodeoxycholic Acid bulk with DMF, CEP offered by ICE Pharma
Find a price of Cholic Acid bulk with CEP, JDMF offered by ICE Pharma
Find a price of Ursodeoxycholic Acid bulk with CEP offered by ICE Pharma
Find a price of Cholic Acid bulk with CEP offered by ICE Pharma
Find a price of Deoxycholic Acid bulk with CEP offered by ICE Pharma
Find a price of Tauroursodeoxycholic Acid bulk with DMF offered by ICE Pharma
Find a price of Dehydrocholic Acid bulk offered by ICE Pharma
Find a price of Doxofylline bulk offered by ICE Pharma
Find a price of Inosine Pranobex bulk offered by ICE Pharma
Find a price of N-Acetyl-D-neuraminate bulk offered by ICE Pharma
Find a price of Taurine bulk offered by ICE Pharma